Skip to content

The application of laryngeal mask airway anesthesia in cardiovascular surgery: a randomized controlled trial

The clinical study of application of laryngeal mask airway anesthesia in cardiovascular surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022311
Enrollment
Unknown
Registered
2019-04-04
Start date
2019-04-08
Completion date
Unknown
Last updated
2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular surgery

Interventions

Laryngeal mask airway: laryngeal mask airway insertion
Tracheal intubation:Tracheal intubation

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Cardiovascular surgery; 3. The cognitive status of patients is good; 4. Classification of cardiac function: I-III.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery; 2. Clinical diagnosis of coagulation dysfunction, severe brain, liver and kidney dysfunction, endocrine system diseases and severe infectious diseases; 3. Patients with difficulty in opening mouth, satiety of stomach, gastrointestinal obstruction, gastroesophageal reflux, BMI > 30 kg/m2, history of severe COPD and other contraindications of laryngeal mask placement; 4. Taboos of Transesophageal echocardiography and Pulmonary Artery Catheterization; 5. Alcohol and drug abuse; 6. Spinal deformity and space-occupying lesions in paravertebral space; 7. Failure to cooperate with research for any reason, such as language comprehension, mental illness, inability to visit a research center, etc.

Design outcomes

Primary

MeasureTime frame
ICU Residence Time;Postoperative mechanical ventilation time;length of hospital stay;

Secondary

MeasureTime frame
post-operative complication rate;Postoperative delirium incidence;Hospitalization expenses;Intraoperative use of analgesics;Serious adverse events;

Countries

China

Contacts

Public ContactE Wang

Department of Anesthesiology, Xiangya Hospital of Central South University

ewang324@hotmail.com+86 18874889950

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026